Electra Therapeutics targets up to $977.6 million valuation
Electra Therapeutics said in a Monday filing that it is targeting a valuation of up to $977.6 million for its U.S. initial public offering.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.